Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Merger of the Lyme Research Alliance and Tick-Borne Disease Alliance Creates Leading Voice for Lyme & Tick-Borne Diseases
  • USA - English


News provided by

Tick-Borne Disease Alliance

May 29, 2014, 14:00 ET

Share this article

Share toX

Share this article

Share toX

New York and Stamford, CT (PRWEB) May 29, 2014 -- The Tick-Borne Disease Alliance (TBDA) and the Lyme Research Alliance (LRA), two of the most influential voices on Lyme and tick-borne diseases, announced today their intention to merge (the “Merger”). The Merger was approved by each of the respective Board of Directors last evening, pending regulatory approval.

The Merger will result in the formation of the largest tick-borne disease organization in the country, allowing for greater resources to be applied to research on urgently needed improvements in diagnostics and treatments, while maintaining awareness programs for the general public and physicians. The groups plan to rename the merged non-profit upon final completion of the Merger.

“Our mutual overarching goal is what moved us forward to consolidate our groups,” states Diane Blanchard, co-founder and co-president of LRA. “The Merger strategically positions us to lead our joint mission to develop improved, accurate, accessible diagnostics and treatment therapies, as well as continue to raise awareness of tick-borne diseases in communities.”

Adds David Roth, co-chairman of TBDA and a managing director of the private equity firm Blackstone Group LP, “the Merger of LRA and TBDA marks the next logical step to helping people learn about this insidious, complicated disease. The Merger presents a new level of cooperation in fundraising, and will provide a platform for a strengthened, unified and collaborative voice to advance the fight to end Lyme disease forever.”

The Merger will harness the expertise of each organization, fueling the innovation potential of its vast network of world-renowned medical experts, physicians, researchers and key medical institutions. This further strengthens proven consumer grass roots awareness campaigns, major national fundraising events and media relations programs. Examples include:

•The leader in funding and financial support for the development of accurate diagnostic testing, and to find a cure for chronic or persistent Lyme infection.

•The first endowed center for the study of chronic Lyme disease at Columbia Lyme and Tick Borne Diseases Center at Columbia University Medical Center, New York.

•The first planned national bio-repository of specimens and data pilot programs throughout the country.

•World-renowned members of a Scientific Advisory Board, including Luc Montagnier, Phd, co-winner of the 2008 Nobel Prize for Physiology or Medicine and the co-discoverer of the human immunodeficiency virus (HIV); Judith Miklossy MD, Phd, director, Alzheimer Research Center, Switzerland, expert in spirochete microbiology; Mark Soloski, Phd, professor of medicine, Johns Hopkins University School of Medicine; Richard Ostfeld, Phd, senior scientist and disease ecologist, Cary Institute of Ecosystem Studies; and Allison DeLong, M.S., biostatistician at Center for Statistical Sciences in the Rhode Island Department of Health.

•Comprehensive public awareness and education campaigns, such as the “Bite Back for a Cure” campaign.

“This new scale enables Lyme disease researchers to access the new tools and technologies which are now coming online that will change the landscape of diagnostic and treatment research with the ultimate promise of an end to the tragedy of this disease,” said Robert Kobre, a member of LRA’s Scientific Advisory Board and a managing director at Credit Suisse.

“We are looking forward to working closely together as a new organization to find the answers that will end the suffering of so many afflicted people, especially children,” said Debbie Siciliano, co-founder and co-president, LRA. “By joining forces we will help to ensure that our progress on research and education makes an even greater impact on the medical community,” adds Charles Balducci, co-chairman of TBDA.

More than 300,000 Americans are infected with Lyme disease each year, 10 times more than previously reported by the Centers for Disease Control and Prevention (CDC). As it often goes undetected, millions more are at risk of developing life-debilitating, potentially deadly conditions. In fact, the National Institutes of Health found that the impact of Lyme disease on people’s health was at least equal to the disability of patients with congestive heart failure, osteoarthritis and greater than those seen in type 2 diabetes.

The original founders of both organizations will continue to play an active role in the combined entity. The Merger will result in a charitable organization with over 25 years of combined experience, a leading non-profit organization for public, medical and government education and the funding of cutting-edge research for the prevention, diagnosis and treatment of Lyme and other tick-borne diseases. For more information about LRA, TBDA and the Merger, please visit http://www.LymeResearchAlliance.org and http://www.TBDAlliance.org.

# # #

Andrea Werbel, Tick-Borne Disease Alliance, http://www.TBDAlliance.org, +1 (212) 372-7630, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.